In this interview, two experts in the field of acute myeloid leukaemia (AML), Jean-Baptiste Micol, University of Paris-Saclay, France, and Thomas Cluzeau, University Hospital of Nice, France, share their views and debate the current landscape of real-world data in AML research and treatment.

Chumi Khurana, Global Head, Prostate Cancer Disease Area Stronghold, Janssen Oncology speaks about her pathway into men’s health and more.

A chat with Kris Aves, Metropolitan police officer, about the Westminster Bridge attack in March 2017 and the implication of his injuries.

Patients with cancer require meticulous, co-ordinated, and individualised management from oncologists and other healthcare professionals. To meet all the needs of the patient, a multidisciplinary team (MDT) approach is favoured, enabling improved decision making and a better clinical outcome. Interestingly, this approach has been associated with improved overall survival and reduced rates of cancer recurrence compared with non-MDT care.

In this episode, we have two experts in the field of Direct Oral Anticoagulants for the treatment of cancer-related venous thromboembolisms.